Key points are not available for this paper at this time.
The sex-related lung cancer survival disparity in this Australian cohort was largely accounted for by known prognostic factors, indicating an opportunity to explore sex differences in treatment preferences, options, and access.
Yu et al. (Fri,) studied this question.